TCTMD

Your source for breaking news, topical videos, and slides covering cardiovascular disease and interventions. Register at

[TCTMD @TCTMD]

Updated ESC Heart Failure Guideline Brings Big Changes https://t.co/RXZPBn52iY

[TCTMD @TCTMD]

PRAGUE-26: Catheter-Directed Thrombolysis Beneficial in Intermediate-High-Risk PE https://t.co/Rx4uEUKtPX

[TCTMD @TCTMD]

What challenges will AI pose for medical education going forward? Thomas Lüscher (@ESC_President) shares the mistakes algorithms can make, as well as how they can challenge physicians to better prioritize empathy in patient care. Watch here: https://t.co/1BGaL8uS8v

[TCTMD @TCTMD]

While the Lp(a)HORIZON trial did not find a reduction in CV events by decreasing lp(a) levels with pelacarsen, the results can help to better understand the relationship between lp(a) lowering and CV outcomes. Read the full story: https://t.co/3a8Li2VxkZ

[TCTMD @TCTMD]

View the webinar of experts, Drs. Ajay Kirtane, Karim Al-Azizi and Ankitkumar Patel, to learn more about the ALL-RISE data and understand how the CathWorks FFRangio™ system is being used in real world cases. https://t.co/ibZM1kGEYG

[Cardiovascular Research Foundation @crfheart]

👟Lace up for White Sneaker Day at #TCT2026 📅 Monday, November 2

A TCT tradition that brings together the best in #InterventionalCardiology for a day packed with:
🧪 Late-breaking research
🫀 Live cases from around the globe
💡 The latest innovations shaping patient care
🤝 Networking with leaders and peers

Learn more and secure your spot today! https://t.co/AtVTqmErlg

#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD

[TCTMD @TCTMD]

Could conduction-system pacing become a viable resynchronization strategy? In His-Alternative II, the strategy was noninferior to biventricular pacing for reverse remodeling in patients with HFrEF. https://t.co/F8Xw0BnjCe #ESCCongress

[TCTMD @TCTMD]

The findings in the phase II TRANQUILITY trial reinforce pacibekitug’s anti-inflammatory effect, but leaves its potential impact on cardiovascular outcomes unresolved. Read more: https://t.co/bnUQF7ITrG #ESCCongress @DLBHATTMD

[Cardiovascular Research Foundation @crfheart]

🚨 Just 50 days until the biggest names, boldest ideas, and most important breakthroughs in cardiovascular medicine take center stage.

The conversations shaping tomorrow start at #TCT2026. Register now and be part of it!🚀🫀 https://t.co/86pBbuoLR1

#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD

[TCTMD @TCTMD]

Fifth Universal Definition of MI Unveiled at ESC 2026 https://t.co/JXdYJE52BQ

[TCTMD @TCTMD]

CLOSURE-AF: Worse Outcomes With LAAO Driven by Results in Women https://t.co/47mUaV0Mfc

[TCTMD @TCTMD]

CMS Finalizes Anticipated Updates to National Coverage of TAVI https://t.co/UVFEAHaHeW

[TCTMD @TCTMD]

Cardiac rehabilitation has moved well beyond exercise-based therapy. The ESC’s first dedicated clinical guideline calls for personalized, multidisciplinary care that addresses patients’ physical health, mental well-being, lifestyle, and long-term recovery. Read more: https://t.co/CIs5InDylI

[TCTMD @TCTMD]

Martin Leon speaks to two experts in the valve community, @PPibarot and Ajit Yoganathan, about how we can better understand bioprosthetic valve performance and durability in order to improve long-term care. Listen to the full episode for more insights: https://t.co/mFgqguf5RI

[TCTMD @TCTMD]

APOC3-Targeting Drug Has Benefits in Severe Hypertriglyceridemia https://t.co/cfc7XkTJfu

[TCTMD @TCTMD]

POPular ACT TAVI results, presented earlier this month at #ESCCongress, reveal that routine protamine reduces the composite outcome of all-cause death or bleeding. The findings still leave room for debate over whether this will change practice. Read more: https://t.co/t6DohM6xHW

[TCTMD @TCTMD]

Bioprosthetic Valve Durability: A Multi-Disciplinary Approach https://t.co/6VC2Cutlbv

[TCTMD @TCTMD]

@mirvatalasnag discusses the path that led her to become the first female interventionalist in the Gulf region, including advice to her younger self, an appreciation for social media, and why loving what you do makes it all worth it: https://t.co/8UhcSu5EGp

[TCTMD @TCTMD]

Beyond CV Events, Evolocumab Lowers All-Cause Mortality: VESALIUS-CV https://t.co/C5ZMqze6Dx

[TCTMD @TCTMD]

#Tirzepatide is moving further into cardiovascular care with a new FDA indication for reducing #cardiovasculardeath, #MI, and #stroke in adults with type 2 diabetes at elevated risk Read more: https://t.co/dKvvmhRpmh